These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1850515)
1. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327. Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE Prostate; 1991; 18(3):215-27. PubMed ID: 1850515 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152 [TBL] [Abstract][Full Text] [Related]
3. TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin. Russo P; Warner JA; Huryk R; Perez G; Heston WD Prostate; 1994 May; 24(5):237-43. PubMed ID: 8170836 [TBL] [Abstract][Full Text] [Related]
4. Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in rats. Zaccheo T; Giudici D; di Salle E Endocr Relat Cancer; 1999 Sep; 6(3):429-35. PubMed ID: 10516856 [TBL] [Abstract][Full Text] [Related]
5. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats. Zaccheo T; Giudici D; Panzeri A; di Salle E Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382 [TBL] [Abstract][Full Text] [Related]
7. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride. Geller J; Sionit L J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893 [TBL] [Abstract][Full Text] [Related]
8. Effects of flutamide and finasteride on rat testicular descent. Spencer JR; Torrado T; Sanchez RS; Vaughan ED; Imperato-McGinley J Endocrinology; 1991 Aug; 129(2):741-8. PubMed ID: 1677329 [TBL] [Abstract][Full Text] [Related]
9. Sequential androgen blockade: a biological study in the inhibition of prostatic growth. Fleshner NE; Trachtenberg J J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549 [TBL] [Abstract][Full Text] [Related]
10. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs. Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778 [TBL] [Abstract][Full Text] [Related]
11. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men. Rittmaster RS; Stoner E; Thompson DL; Nance D; Lasseter KC J Androl; 1989; 10(4):259-62. PubMed ID: 2550402 [TBL] [Abstract][Full Text] [Related]
12. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen. Geller J J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965 [TBL] [Abstract][Full Text] [Related]
13. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma. Zaccheo T; Giudici D; di Salle E Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146 [TBL] [Abstract][Full Text] [Related]
14. Effects of finasteride on the rat ventral prostate. Shao TC; Kong A; Marafelia P; Cunningham GR J Androl; 1993; 14(2):79-86. PubMed ID: 8390428 [TBL] [Abstract][Full Text] [Related]
15. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition. Rhodes L; Primka RL; Berman C; Vergult G; Gabriel M; Pierre-Malice M; Gibelin B Prostate; 1993; 22(1):43-51. PubMed ID: 8381228 [TBL] [Abstract][Full Text] [Related]
16. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat. di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
19. Effects of perinatal exposure to flutamide on sex hormone responsiveness in F1 male rats. Miyata K; Yabushita S; Sano M; Miyashita K; Okuno Y; Matsuo M J Toxicol Sci; 2003 Aug; 28(3):149-63. PubMed ID: 12974607 [TBL] [Abstract][Full Text] [Related]
20. Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the rat. Zaccheo T; Giudici D; di Salle E J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):193-8. PubMed ID: 9605414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]